China-based biopharmaceutical firm AffaMed Therapeutics has established its digital medicines subsidiary, AffaMed Digital.
Based on a press release, the newly formed unit will focus on developing and marketing evidence-based, clinically validated digital medicines to treat, diagnose, prevent and manage medical disorders or diseases, either as stand-alone novel treatment options or alongside...
BeMe Health, a digital behavioral health tool geared towards teens, has raised $7 million in seed funding from Polaris Partners and Flare Capital Partners.
BeMe offers teens mental health content, coaching, self-guided activities and telehealth support on a platform that looks and feels like social media, gaming and streaming sites.
The company said it plans to use the funding to scale the use of...
Digital behavioral health company SonderMind has acquired Qntfy, a predictive-analytics platform that uses mental health biometric data to suggest potential treatment options.
“Qntfy was always rooted in making data work for the individual,” Qntfy founder Glen Coppersmith said in a statement. Coppersmith will serve as chief data officer at SonderMind.
“I am thrilled to be working with SonderMind...
Virtual addiction treatment Workit Health raised $118 million in Series C funding led by Insight Partners.
Other investors participating in the round include CVS Health Ventures, FirstMark Capital, BCBS Venture Fund, and 3L Capital.
"Workit is at the forefront of massive acceleration in telemedicine adoption, which is key to solving the overdose crisis that was exacerbated by COVID-19. The risk...
In the final podcast in our Virtual Care paradigm series, we look at how virtual care for mental health can benefit not only patients, but also physicians themselves, who face many barriers to mental health care and as a result suffer from high levels of stress, burnout, and even suicide. To discuss this issue and its potential solution, host Jonah Comstock is joined by Kavi Misri, founder and...
Sumitomo Dainippon Pharma Co. in Japan and US-based behavioural health firm BehaVR have signed definitive agreements to develop and market general wellness products and prescription digital therapeutics for the treatment of major mental health disorders.
WHAT IT'S ABOUT
Sumitomo Dainippon Pharma is engaged in the research and development of new pharmaceutical products in the areas of psychiatry...
Pediatric behavioral health platform Brightline will launch a program for children with autism spectrum disorder in early 2022.
The company will also expand content and coaching geared toward youth who identify as LGBTQ, and Black, Indigenous or other children of color, expected to be available early next year. Brightline announced a Clinical Advisory Board that aims to help develop more programs...
Digital mental health titans Ginger and Headspace have officially closed their merger in a deal that reportedly values the combined company at $3 billion.
Now operating as Headspace Health, the newly formed entity brings together Headspace’s direct-to-consumer mindfulness and meditation app with Ginger’s on-demand digital mental health coaching and video therapy platform.
By their joining forces...
Virtual eating disorder treatment Equip announced Thursday it’s expanding into Colorado, Florida, Georgia and Illinois.
The at-home model engages the patient’s family in treatment and pairs the patient with a care team that includes a therapist, dietician and physician alongside family and peer mentors.
Equip said its program will be covered through Optum immediately in Colorado, Florida and...
Pear Therapeutics announced Wednesday that Massachusetts’ Medicaid program plans to cover its digital prescription therapeutics for treating substance and opioid use disorders, reSET and reSET-O.
The decision to cover the digital therapeutics under MassHealth is subject to federal and state approval as well as the availability of funding.
“We applaud MassHealth for their leadership in introducing...